[MUSIC PLAYING] TIM GREINER: I'm Tim Greiner. I am the director of the pathology section of six faculty members in the Department of Pathology and Microbiology. I am also the director of the hematopathology fellowship program. 

ALLISON CUSHMAN-VOKOUN: My name is Allison Cushman-Vokoun, and I'm the medical director of the Molecular Diagnostics Laboratory at Nebraska Medicine. And I'm also the fellowship director for the MGP fellowship program at the University of Nebraska Medical Center. 

TIM GREINER: It's important for residents to know who are considering our fellowship program that we have everything under one roof. This includes a full service flow cytometry, immunohistochemistry, molecular and cytogenetics lab. We are able to work up practically every single case here on site. 

ALLISON CUSHMAN-VOKOUN: Probably the most important thing in a fellow is that they get along well with others and work hard. We have a great staff in our molecular diagnostics lab. Our technologists are second to none, and they really enjoy having the fellows and the residents around and teaching them. They're excellent teachers. And so I really want someone who's going to come in and work hard, interact well with the technologists, and really be receptive to the technologists teaching them and asking them questions and asking them to perform tasks that might need to be done. 

TIM GREINER: One of the important features of our training program is a slide conference on Monday morning of last week's interesting cases. Fellows who might be on a molecular rotation, or cytogenetics rotation, or a flow cytometry rotation has the opportunity to see cases that the other fellows have signed out during the past week. 

JOHN CANNATELLA: The Lymphoma Study Group drew me to Nebraska Medicine to help with more clinical practice, as well as offer a lot of research opportunities. 

CATALINA AMADOR: We have a huge tissue bank and a lot of well-annotated cases. So if a resident fellow has an interest to do research projects, there's a lot of material here from the last 20 years, a lot of rare cases that are well annotated. And we have support to pull cases, do stains, et cetera. So if the interest is an academic career, I think that there are several opportunities here. 

ALLISON CUSHMAN-VOKOUN: We have, like I said, very strong oncology here. We see tumors from every part of the body. We specialize especially in hemepath lymphoma and leukemias. But we also are very strong in gastrointestinal cancers, neurological cancers, and see lots of lung and thoracic oncology as well. And we're growing in areas, I think, in urothelial cancers as well. And so we're really trying to target a lot of our molecular diagnostics capability in these areas to, again, assist both our clinicians in both the clinical care of the patients, but also in growing our clinical trials network. 

SHELLY M. LEWIS: We have extremely experienced staff. But in order for others to carry on the success we have here, we have to have people that want to go above and beyond those boundaries and come in and be part of our program to carry on the legacy. 

ALLISON CUSHMAN-VOKOUN: I would just say that the hospital is extremely supportive of education here at Nebraska Medicine. They realize it's one of the missions of the hospital, is to be a training hospital. And I feel if there's something that we need, they try their best to try and get us what we need in order to make sure it's a great educational experience for our fellows and residents here. 

[MUSIC PLAYING]